-
Populations With Unique Enzymes More Susceptible To COVID-19, Other News
Jul 16, 2020, 11:10 AM by Michael CroftFull storyBio-IT World | Researchers from Cleveland Clinic have found unique genetic susceptibility to COVID-19 across populations in ACE2 and TMPRSS2. Elsewhere, the University of California Health has developed a unified, secure data set for use in COVID-19 research. This, plus more, is included in this week’s COVID-19 news from the biotech and research industries.
-
Court Square Group and Data Conversion Laboratory Announce Partnership to Provide Intelligent Content Solutions to Life Sciences Market
Jul 15, 2020, 15:18 PM by Michael CroftSPRINGFIELD, MA, UNITED STATES - Jul 15, 2020 - Court Square Group, the leading provider of an Audit Ready Compliant Cloud (ARCC) platform for Life Science companies, and Data Conversion Laboratory (DCL), an industry leader in structured data and content transformations, today announce a new partnership for global life sciences organizationsFull story -
In The Midst Of A Pandemic, Duplex Sequencing Comes Of Age
Jul 15, 2020, 08:30 AM by Michael CroftFull storyBio-IT World | Duplex Sequencing, a technique for improving the accuracy of next-generation sequencing by more than 10,000-fold, could eliminate a good deal of the guesswork in advancing drugs to market.
-
Alfa Chemistry Testing Lab Provides Customized Pharmaceutical Analytical Services
Jul 14, 2020, 23:17 PM by Michael CroftNY, NY, UNITED STATES - Jul 14, 2020 - July 14, 2020, New York, USA - Alfa Chemistry Testing Lab announced today that it has recently launched customized pharmaceutical analytical services for companies involved with new drug developmentFull story -
1CellBio to Offer Dual-Indexed Library Design Capability for inDrop™ System to Improve Throughput and Cost-Effectiveness for Large-Scale Single-Cell RNA Sequencing Studies
Jul 14, 2020, 08:47 AM by Michael CroftWATERTOWN, MA, UNITED STATES - Jul 14, 2020 - 1CellBio, Inc., announced today a new dual indexed library design capability that improves costs, throughput and data quality for its inDrop single-cell RNA sequencing (scRNA-seq) SystemFull story -
Breaking Silos to Enable Breakthroughs
Jul 14, 2020, 08:15 AM by Michael CroftFull storyBio-IT World | TRENDS FROM THE TRENCHES | For most big pharma and other global enterprises, decades of growth have resulted in siloed operations, even as they seek breakthrough medicines. It is time for such a breakthrough; as an industry, we’re overdue.
-
Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia
Jul 14, 2020, 07:01 AM by Michael CroftSAN DIEGO, CA, UNITED STATES - Jul 14, 2020 - Invivoscribe, Inc., an industry pioneer and global leader in the field of precision diagnostics announces the launch of a fully integrated drug development engineFull story -
Audit of Check4Cancer’s One Stop Breast Clinic network confirms clinical excellence in the private sector
Jul 14, 2020, 05:19 AM by Michael CroftCAMBRIDGE, UK - Jul 14, 2020 - Cambridge, UK, 14th July 2020 / Sciad Newswire / Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, announces audit results from its private breast cancer diagnostic pathway, confirming Check4Cancer's One Stop Breast Clinic network provides clinical excellence for patients experiencing symptoms of breast cancerFull story -
Elucid Digital Health’s dashboard gives pharma and CROs real time patient adherence data during a clinical trial
Jul 13, 2020, 10:46 AM by Michael CroftMANCHESTER, UNITED KINGDOM - Jul 13, 2020 - Elucids Pill Connect dispensing system provides CROs and pharma the ability to show adherence across the whole trial, by country, by site even down to the individual patient number in real timeFull story -
Creative Proteomics Launches Untargeted Metabolomics Services for Drug Development
Jul 13, 2020, 04:36 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 13, 2020 - Creative Proteomics, an integrated CRO company that provides a full range of drug development services, has recently launched its fully-developed untargeted metabolomics services to researchersFull story -
CD Genomics Announces MicroCollect™ FDA&CE Certificated Virus Collection Swab Kits for SARS-CoV-2 Detection
Jul 13, 2020, 04:31 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 13, 2020 - CD Genomics, an internationally leading provider of microbial testing services, microbial genomics services, and integrated bioinformatics services for hospitals, food, diagnostics, pharma, agriculture, biotechnology, and research institutes, announces advanced virus collection kit for SARS-CoV-2 detectionFull story -
Creative Enzymes Optimizes Enzyme Stabilization and Formulation Services
Jul 13, 2020, 04:27 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 13, 2020 - As an excellent supplier and manufacturer, Creative Enzymes has recently optimized enzyme stabilization and formulation services for researchers working in the life science fieldFull story -
Illumina Launches TruSight Software Suite, Accelerating Identification of Genetic Diseases
Jul 10, 2020, 10:05 AM by Michael CroftFull storyBio-IT World News Brief | Illumina, in collaboration with Mayo Clinic and other key opinion leaders, has launched its TruSight Software Suite in an effort to bring turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing.
-
Study Says Prior Infection Could Prevent Reinfection, Other COVID-19 News
Jul 10, 2020, 08:35 AM by Michael CroftFull storyBio-IT World | Animal models are showing how prior infection of the SARS-CoV-2 virus can provide protection against reinfection. Elsewhere, a coronavirus task force task force is examining genes associated with COVID-19 immune response by collecting samples from Japanese patients. This, plus more, are featured in this week’s COVID-19 news from the biotech and research industries.
-
Wearable, Wireless Biometric Sensor Devices from Shimmer Provide Much-Needed Patient Data in Battle Against COVID-19
Jul 9, 2020, 14:57 PM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Jul 9, 2020 - Shimmer, a leading provider of wearable wireless sensor products and solutions, has partnered with the University of South Florida to develop an early warning system, including a wearable device, to help detect the progression of COVID-19 for those most at risk of severe infectionFull story -
TrialScope Expands Leadership Team with New Chief Commercial Officer
Jul 9, 2020, 11:22 AM by Michael CroftJERSEY CITY, NJ, UNITED STATES - Jul 9, 2020 - TrialScope, the global leader in clinical trial transparency, has hired Chris Venezia as Chief Commercial Officer, expanding its executive teamFull story -
Virtual Twins: Their Roles In Healthcare, Drug Discovery, And Pandemic Response
Jul 9, 2020, 10:10 AM by Michael CroftFull storyBio-IT World | In a world that has shifted to virtual everything—work, recreation, connection—it’s no wonder that virtual or digital twins are getting more attention. It’s certainly a favorite term of marketers: we are creating digital twins for everything from people to businesses, instruments to labs.
-
HENRY SCHEIN MEDICAL ANNOUNCES EXPANSION OF MEDPOD’S TELEMEDICINE SOLUTIONS WITH INTEGRATION OF VISUALDX
Jul 9, 2020, 10:02 AM by Michael CroftMELVILLE, NY, UNITED STATES - Jul 9, 2020 - Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. and exclusive distributor of Medpod, IncFull story -
SCL Health Partners with Kyruus to Enhance Consumer and Provider Experience
Jul 8, 2020, 11:17 AM by Michael CroftBOSTON, MA, UNITED STATES - Jul 8, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, and SCL Health, a faith-based nonprofit health system providing care across Colorado, Kansas, and Montana, today announced that SCL Health has selected Kyruus patient access and provider data management platform to enable its digital access initiativesFull story -
Absolute Antibody and University of Zurich Collaborate to Offer Synthetic Nanobodies Against SARS-CoV-2 Receptor Binding Domain
Jul 8, 2020, 09:53 AM by Michael CroftREDCAR, UNITED KINGDOM - Jul 8, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2, the coronavirus that causes COVID-19Full story